Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Knot

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Thrombosis and Haemostasis|February 25, 1988
Mild haemostatic problems associated with congenital heterozygous alpha 2-antiplasmin deficiencyF W Leebeek, J Stibbe, E A Knot, et al.
Thrombosis Research|February 15, 1991
Correlations between plasma levels of fibrin(ogen) derivatives as quantified by different assays based on monoclonal antibodiesH Kroneman, W Nieuwenhuizen, E A Knot, et al.
Thrombosis Research|December 1, 1988
Acid treatment of plasma for the inactivation of plasminogen activator inhibitor-1 (PAI-1)M P de Maat, C Kluft, K de Boer, et al.
Journal of the American College of Cardiology|May 1, 1990
Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasminF W Leebeek, C Kluft, E A Knot, et al.
Haemostasis|January 1, 1991
Diagnostic value of D-dimer for deep venous thrombosis in outpatientsH Kroneman, P F Van Bergen, E A Knot, et al.
Thrombosis Research|May 15, 1995
Measuring plasma fibrinogen levels in patients with liver cirrhosis. The occurrence of proteolytic fibrin(ogen) degradation products and their influence on several fibrinogen assaysM P de Maat, W Nieuwenhuizen, E A Knot, et al.
Thrombosis and Haemostasis|December 18, 1987
Antithrombin III: biodistribution in healthy volunteersE A Knot, E de Jong, J W ten Cate, et al.
Transplantation|June 1, 1989
Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantationR J Porte, F A Bontempo, E A Knot, et al.
Thrombosis and Haemostasis|December 29, 1989
Is quantitative determination of fibrin(ogen) degradation products and thrombin-antithrombin III complexes useful to diagnose deep venous thrombosis in outpatients?P F van Bergen, E A Knot, J J Jonker, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 1, 1991
A comparative study on changes in hemostasis in orthotopic and auxiliary liver transplantation in pigsR J Porte, J D Blankensteijn, E A Knot, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Thrombosis and Haemostasis|February 25, 1988
Mild haemostatic problems associated with congenital heterozygous alpha 2-antiplasmin deficiencyF W Leebeek, J Stibbe, E A Knot, et al.
Thrombosis Research|February 15, 1991
Correlations between plasma levels of fibrin(ogen) derivatives as quantified by different assays based on monoclonal antibodiesH Kroneman, W Nieuwenhuizen, E A Knot, et al.
Thrombosis Research|December 1, 1988
Acid treatment of plasma for the inactivation of plasminogen activator inhibitor-1 (PAI-1)M P de Maat, C Kluft, K de Boer, et al.
Journal of the American College of Cardiology|May 1, 1990
Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasminF W Leebeek, C Kluft, E A Knot, et al.
Haemostasis|January 1, 1991
Diagnostic value of D-dimer for deep venous thrombosis in outpatientsH Kroneman, P F Van Bergen, E A Knot, et al.
Thrombosis Research|May 15, 1995
Measuring plasma fibrinogen levels in patients with liver cirrhosis. The occurrence of proteolytic fibrin(ogen) degradation products and their influence on several fibrinogen assaysM P de Maat, W Nieuwenhuizen, E A Knot, et al.
Thrombosis and Haemostasis|December 18, 1987
Antithrombin III: biodistribution in healthy volunteersE A Knot, E de Jong, J W ten Cate, et al.
Transplantation|June 1, 1989
Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantationR J Porte, F A Bontempo, E A Knot, et al.
Thrombosis and Haemostasis|December 29, 1989
Is quantitative determination of fibrin(ogen) degradation products and thrombin-antithrombin III complexes useful to diagnose deep venous thrombosis in outpatients?P F van Bergen, E A Knot, J J Jonker, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 1, 1991
A comparative study on changes in hemostasis in orthotopic and auxiliary liver transplantation in pigsR J Porte, J D Blankensteijn, E A Knot, et al.
Pageof 3